Priming of dendritic cells with TAA (MHC I, HSP70, HSP90, Mart1, and Her2/Neu) carrying exosomes derived from ovarian cancer ascites and subsequent exposure to resting T cells resulted in T cell activation and increased tumor cell cytotoxicity [82]. Here, ERBB2 is linked to ovarian cancer.